Key result
Plasma N-ANP was positively related to flow-mediated dilation and inversely related to baseline mean flow velocity among 7 biomarkers tested.
Why the study?
Do specific biomarkers from distinct biological pathways correlate with brachial artery endothelial function in a community-based sample?
Cross-Sectional (n=2,113)
Do specific biomarkers from distinct biological pathways correlate with brachial artery endothelial function in a community-based sample?
Plasma N-ANP is a key correlate of mean flow under basal conditions and of flow-mediated dilation in response to forearm cuff occlusion in a community-based sample.
Answers are grounded in this paper and cite their sources.
N-ANP association with endothelial function is hypothesis-generating; should not yet inform clinical risk assessment in community samples.
BACKGROUND: Endothelial dysfunction is a critical intermediate phenotype in the pathogenesis of cardiovascular disease. We evaluated the relative contributions of distinct biological pathways to interindividual variation in endothelial function by relating prototype biomarkers (representing these pathways) to brachial artery vasodilator function. METHODS AND RESULTS: We investigated the cross-sectional relations of a panel of 7 biomarkers measured at a routine examination to brachial artery vasodilator function (flow-mediated dilation [FMD] and reactive hyperemia) assessed at a subsequent examination (mean interval, 2.9 years) in 2113 Framingham Heart Study participants (mean age, 61 years; 54% women). We selected biomarkers from 4 biological domains: neurohormonal (N-terminal pro-atrial natriuretic peptide [N-ANP], B-type natriuretic peptide [BNP], renin, aldosterone), hemostatic factors (plasminogen activator inhibitor-1 [PAI-1]), inflammation (C-reactive protein [CRP]), and target organ damage (urine albumin-creatinine ratio). In age- and sex-adjusted models, several biomarkers were related to baseline brachial artery diameter (PAI-1, CRP, urine albumin-creatinine ratio), baseline mean flow (N-ANP, BNP, PAI-1, CRP, aldosterone), FMD (N-ANP, PAI-1, CRP, renin), and reactive hyperemia (BNP, PAI-1, CRP, renin, urine albumin-creatinine ratio). In multivariable analyses relating the 7 biomarkers conjointly to each vascular function measure (adjusting for known risk factors), N-ANP and renin were positively related to FMD (P=0.001 and P=0.04, respectively), and N-ANP was inversely related to baseline mean flow velocity (P=0.01). None of the other biomarkers was significantly related to the vascular function measures studied. CONCLUSIONS: In our large community-based sample, a conservative strategy relating several biomarkers to vascular endothelial function identified plasma N-ANP as a key correlate of mean flow under basal conditions and of FMD in response to forearm cuff occlusion.
No takes yet. Share an insight, caveat, or question.
Kathiresan et al. (2006) conducted a cross-sectional in Endothelial dysfunction (n=2,113). Multiple biomarkers (N-ANP, BNP, renin, aldosterone, PAI-1, CRP, urine albumin-creatinine ratio) was evaluated on Brachial artery vasodilator function (flow-mediated dilation and reactive hyperemia) (p=0.001). Plasma N-ANP was positively related to flow-mediated dilation and inversely related to baseline mean flow velocity among 7 biomarkers tested.
Synapse has enriched 10 related papers. Consider them for comparative context: